Advance Search
ZHAO Xiaohui, LI Shuang. Correlations between expressions of SEPT9 gene methylation, growth differentiation factor 15, carbohydrate antigen 199 and clinicopathologic features, prognosis in patients with colorectal cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(24): 52-56. DOI: 10.7619/jcmp.20213287
Citation: ZHAO Xiaohui, LI Shuang. Correlations between expressions of SEPT9 gene methylation, growth differentiation factor 15, carbohydrate antigen 199 and clinicopathologic features, prognosis in patients with colorectal cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(24): 52-56. DOI: 10.7619/jcmp.20213287
shu

Correlations between expressions of SEPT9 gene methylation, growth differentiation factor 15, carbohydrate antigen 199 and clinicopathologic features, prognosis in patients with colorectal cancer

  • Department of Laboratory, Shunyi Hospital of Beijing Traditional Chinese Medicine Hospital, Beijing, 101300

More Information
  • Received Date: August 15, 2021
  • Available Online: January 04, 2022
  • Published Date: December 27, 2021
    Graphical Abstract
    • Abstract
  •   Objective  To investigate the expressions of SEPT9 gene methylation (mSEPT9), growth differentiation factor 15 (GDF15) and carbohydrate antigen 199 (CA199) in patients with colorectal cancer, and to analyze their relationships with clinicopathological features and prognosis.
      Methods  Blood samples from 218 inpatients admitted to the Anorectal Department were retrospectively analyzed, including 106 patients with colorectal cancer in cancer group and 112 patients with colorectal adenoma in adenoma group. A total of 100 healthy people were collected as control group. The positive rates of mSEPT9, GDF15 and CA199 in the three groups were compared, and the relationships between mSEPT9, GDF15, CA199 and clinicopathological features, prognosis of colorectal cancer patients were investigated.
      Results  The positive rate of mSEPT9, levels ofGDF15 and CA199 in the cancer group were significantly higher than those in the adenoma group and the control group, and were higher in the adenoma group than those in the control group (P < 0.05). The levels of mSEPT9, GDF15 and CA199TNM in patients in stage Ⅲ to Ⅳ, infiltration depth below serosal layer, low differentiation, lymph node metastasis and distant metastasis were significantly increased (P < 0.05). Pearson correlation analysis showed that mSEPT9, GDF15, CA199 were significantly correlated with TNM stage, infiltration depth, differentiation degree, lymph node metastasis and distant metastasis (P < 0.05). High clinical stage, low degree of differentiation, lymph node metastasis, distant metastasis and positive expressions of mSEPT9, GDF15 and CA199 were independent risk factors for poor prognosis in colorectal cancer patients (P < 0.05).
      Conclusion  The expressions of mSEPT9, GDF15, and CA199 in colorectal cancer patients are significantly increased, and are closely related to different clinicopathological features. Positive expressions of mSEPT9, GDF15, and CA199 are independent risk factors for poor prognosis. Clinical intervention should be strengthened to improve the prognosis and survival rate of patients.
    • FullText(HTML)
    • References (19)
  • [1]
    王志正, 王子元, 黎文明, 等. 结直肠癌组织中长链非编码RNA LINC01617的表达及其对结直肠癌细胞增殖的作用[J]. 沈阳药科大学学报, 2020, 37(8): 730-735. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYD202008011.htm
    [2]
    张桂前, 孙鷖, 朱红艳, 等. 血浆SEPT9基因甲基化检测在结直肠癌筛查中的应用分析[J]. 中华肿瘤防治杂志, 2020, 27(15): 1263-1268. https://www.cnki.com.cn/Article/CJFDTOTAL-QLZL202015016.htm
    [3]
    毕晓峰, 张超, 李茉, 等. 血清GDF15诊断及筛查结直肠癌的临床价值[J]. 中国肿瘤, 2020, 29(12): 970-975. doi: 10.11735/j.issn.1004-0242.2020.12.A014
    [4]
    张鑫东, 葛晓蕾, 刘省存, 等. 血清CA199和CEA对结直肠癌转移和预后预测的价值[J]. 中华疾病控制杂志, 2018, 22(1): 57-61. https://www.cnki.com.cn/Article/CJFDTOTAL-JBKZ201801014.htm
    [5]
    中华人民共和国国家卫生健康委员会. 中国结直肠癌诊疗规范(2020年版)[J]. 中华外科杂志, 2020, 58(8): 561-585. doi: 10.3760/cma.j.cn112139-20200518-00390
    [6]
    ARNOLD M, ABNET C C, NEALE R E, et al. Global burden of 5 major types of gastrointestinal cancer[J]. Gastroenterology, 2020, 159(1): 335-349. doi: 10.1053/j.gastro.2020.02.068
    [7]
    曾红平. 7392例大便常规检查阳性率调查分析[J]. 实验与检验医学, 2020, 38(4): 780-782. doi: 10.3969/j.issn.1674-1129.2020.04.056
    [8]
    张姣, 陈志仁, 梁妍, 等. PET-MRI检查技术在结直肠癌诊断中的应用进展[J]. 中国实验诊断学, 2021, 25(1): 134-136. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSZD202101040.htm
    [9]
    吴秀方, 南琼, 张晓红, 等. 血浆SEPT9甲基化检测对结直肠癌诊断价值的临床研究[J]. 中国全科医学, 2021, 24(15): 1915-1919. doi: 10.12114/j.issn.1007-9572.2021.00.136
    [10]
    冷霞, 王芳军, 周培, 等. 外周血SEPT9基因甲基化检测联合糖蛋白肿瘤标志物在结直肠癌诊断中的应用[J]. 胃肠病学, 2019, 24(6): 362-365. doi: 10.3969/j.issn.1008-7125.2019.06.009
    [11]
    高云鸽, 程天一, 钱罗蒙, 等. GDF-15在肿瘤发生发展及免疫调节中作用的研究进展[J]. 中国免疫学杂志, 2020, 17(14): 1784-1787. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMXZ202014027.htm
    [12]
    马琛茹, 关泉林, 郝建鹏, 等. 血清Hcy、CEA、CA199对结直肠癌诊断值及其分期的相关性研究[J]. 西部医学, 2019, 31(10): 1549-1553. https://www.cnki.com.cn/Article/CJFDTOTAL-XIBU201910016.htm
    [13]
    曹亚萍, 赵国栋, 刘益, 等. 血浆胞裂蛋白9和多配体蛋白聚糖2前体甲基化联合检测与4种血清肿瘤标志物对结直肠癌诊断效果的对比性研究[J]. 中国综合临床, 2021, 37(2): 105-111. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_zgzhlc202102002
    [14]
    邱智宇. 结直肠癌筛查方法研究进展[J]. 肿瘤预防与治疗, 2019, 32(11): 1024-1030. https://www.cnki.com.cn/Article/CJFDTOTAL-SCZF201911016.htm
    [15]
    赛亚飞, 高美丽, 金发光, 等. 血清肿瘤标志物CEA、CA125、CYFRA21-1在支气管肺癌诊断、病理类型及TNM分期中的价值分析[J]. 中华肺部疾病杂志: 电子版, 2019, 12(1): 34-37. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFBD201901006.htm
    [16]
    李红, 胡林莉, 贾环. 浸润深度与结直肠癌患者临床特征及预后的关系[J]. 癌症进展, 2021, 19(3): 290-293. https://www.cnki.com.cn/Article/CJFDTOTAL-AZJZ202103020.htm
    [17]
    闫秋芳, 杨继闽. 梗阻性结直肠癌患者的临床病理特点及生存状况分析[J]. 新乡医学院学报, 2019, 36(7): 673-676. https://www.cnki.com.cn/Article/CJFDTOTAL-XXYX201907018.htm
    [18]
    郭源, 李云龙, 张龙, 等. T3、T4期结直肠癌淋巴结转移危险因素分析[J]. 肿瘤研究与临床, 2020, 32(3): 161-165. http://med.wanfangdata.com.cn/Paper/Detail?id=PeriodicalPaper_zlyjylc202003019&dbid=WF_QK
    [19]
    张煌, 鲁恒珍, 周帅跃, 等. 血清微小RNA-106b-5p、RNA-30a-5p水平与结直肠癌患者预后的关系及其诊断价值[J]. 疑难病杂志, 2020, 19(12): 1238-1242, 1247. https://www.cnki.com.cn/Article/CJFDTOTAL-YNBZ202012013.htm
    • Related Articles

  • Related Articles

    [1]FANG Liya, LIU Yuanyuan, LIU Jiahao, LI Jiawei, ZENG Pei, GUO Jin. Research progress in microRNAs as potential biomarkers in temporal lobe epilepsy[J]. Journal of Clinical Medicine in Practice, 2025, 29(1): 130-135. DOI: 10.7619/jcmp.20243845
    [2]SHAN Xiaoli, CHI Runze, YU Xin, LI Bingong. Correlation between left atrial diameter and renal function in patients with atrial fibrillation[J]. Journal of Clinical Medicine in Practice, 2024, 28(9): 34-39. DOI: 10.7619/jcmp.20240497
    [3]WANG Tianwei, TANG Chengbin, JIANG Wei, YU Hailong, SHAO Jun, YUAN Jing. Research progress on early biomarkers of cardiac surgery-associated acute kidney injury[J]. Journal of Clinical Medicine in Practice, 2024, 28(3): 131-139, 143. DOI: 10.7619/jcmp.20232815
    [4]ZHANG Chen, YANG Zhen, ZHAO Yi, YANG Xiaoli. Prognostic biomarkers of multimodal imaging in central serous chorioretinopathy[J]. Journal of Clinical Medicine in Practice, 2023, 27(4): 133-137, 143. DOI: 10.7619/jcmp.20223176
    [5]ZHOU Dan, LI Xiuli, HU Hao, ZHAI Shaopeng, WANG Manxia. Clinical value of diagnostic biomarkers for patent foramen ovale-associated stroke[J]. Journal of Clinical Medicine in Practice, 2023, 27(2): 134-138. DOI: 10.7619/jcmp.20222935
    [6]YOU Jing, HE Miao, ZHOU Feng, LI Weirong. Research progress on roles of blood biomarkers in etiological classification of ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2022, 26(6): 118-122. DOI: 10.7619/jcmp.20214524
    [7]LIU Jiujiang, LIN Hua. Research progress of serum biomarkers in acute respiratory distress syndrome[J]. Journal of Clinical Medicine in Practice, 2021, 25(23): 124-128. DOI: 10.7619/jcmp.20213576
    [8]ZHANG Naiying, LI Bo. Detection of serum biomarkers related to type 2 diabetes mellitus and their analysis[J]. Journal of Clinical Medicine in Practice, 2020, 24(21): 79-81. DOI: 10.7619/jcmp.202021023
    [9]ZHOU Lei, GAO Zhanqiang. Analysis on coagulation indexes, biochemical indexes and occurrence of venous thrombosis in patients with heart failure and atrial fibrillation[J]. Journal of Clinical Medicine in Practice, 2020, 24(18): 50-53. DOI: 10.7619/jcmp.202018014
    [10]WU Xiaoxia, YU Xinyue, HUANG Yin, LIU Peifang. Network-based analysis of blood metabolic biomarkers for stroke[J]. Journal of Clinical Medicine in Practice, 2020, 24(18): 1-6. DOI: 10.7619/jcmp.202018001

Catalog

    Get Citation
    PDF
    XML
    Article views (229) PDF downloads (17) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return